Cabozantinib<unk><unk>  is a common adverse reaction to cytotoxic<unk>  drugs, particularly cabozantinib, cytarabine, doxorubicin, and fluorouracil and its prodrug capecitabine. Targeted cancer therapies, especially the tyrosine kinase inhibitors sorafenib and sunitinib, have also been associated with a high incidence of<unk><unk> . However,<unk><unk>  due to tyrosine kinase inhibitors seems to differ somewhat from<unk><unk>  due to classic<unk>  drugs.
Chemotherapy-induced acral erythema
Diabetic dermadrome
Cutaneous lymphoma
Diabetic dermopathy
Chronic actinic dermatitis
Neutrophilic eccrine hidradenitis
Lupus vulgaris
Parapsoriasis